{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:36:16Z","timestamp":1786988176758,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejso.2026.111397","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:46:20Z","timestamp":1768981580000},"page":"111397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surgery for Colorectal Peritoneal Metastases in non-expert centers is strongly associated with tumor persistence or early recurrence: a bicentric study of 106 patients"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2063-3836","authenticated-orcid":false,"given":"Barbara","family":"Noiret","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-8600","authenticated-orcid":false,"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Provost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8243-8310","authenticated-orcid":false,"given":"Guillaume","family":"Piessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-4974","authenticated-orcid":false,"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8804-4929","authenticated-orcid":false,"given":"Clarisse","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2026.111397_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.ejso.2026.111397_bib2","first-page":"1026","article-title":"Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: a nationwide study","volume":"47","author":"Lurvink","year":"2021","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.111397_bib3","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and research in cancers of the digestive system (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2026.111397_bib4","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.3390\/jcm12113774","article-title":"Treatment of peritoneal surface malignancies by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in Spain: results of the national registry of the Spanish group of peritoneal oncologic surgery (REGECOP)","volume":"12","author":"Manzanedo","year":"2023","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ejso.2026.111397_bib5","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1245\/s10434-014-4111-x","article-title":"Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies","volume":"22","author":"Polanco","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.111397_bib6","first-page":"1671","article-title":"Cytoreductive surgery with a hyperthermic intraperitoneal chemotherapy program: safe after 40 cases, but only controlled after 140 cases","volume":"41","author":"Voron","year":"2015","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2026.111397_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/SLA.0000000000004326","article-title":"Centralization and oncologic training reduce postoperative morbidity and failure-to-rescue rates after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: study on a 10-year national French practice","volume":"272","author":"Noiret","year":"2020","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.111397_bib8","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2026.111397_bib9","article-title":"The attitude and practice of general surgeons toward cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a cross-sectional study","volume":"66","author":"Bin Traiki","year":"2012","journal-title":"Ann Med Surg"},{"issue":"11","key":"10.1016\/j.ejso.2026.111397_bib10","first-page":"2888","article-title":"The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: a web-based survey and 2021 statement by peritoneal surface oncology group international (PSOGI)","volume":"47","author":"van de Vlasakker","year":"2021","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111397_bib11","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1245\/s10434-024-15131-0","article-title":"Towards equal access to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy and survival in patients with isolated colorectal peritoneal metastases: a nationwide population-based study","volume":"31","author":"van der Ven","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111397_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.12.034","article-title":"Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: a nationwide population-based study","volume":"75","author":"Rovers","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"issue":"2","key":"10.1016\/j.ejso.2026.111397_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.111397_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/SLA.0b013e31822638f6","article-title":"Results of systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis","volume":"254","author":"Elias","year":"2011","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.ejso.2026.111397_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jviscsurg.2015.01.002","article-title":"Routine second-look after surgical treatment of colonic peritoneal carcinomatosis","volume":"152","author":"Delhorme","year":"2015","journal-title":"J Vis Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.111397_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ciresp.2017.11.006","article-title":"Systematic second-look surgery plus HIPEC in patients without evidence of recurrence, at high risk of carcinomatosis after colorectal cancer resection","volume":"96","author":"Serrano Del Moral","year":"2018","journal-title":"Cir Esp"},{"issue":"9","key":"10.1016\/j.ejso.2026.111397_bib17","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1245\/s10434-024-15180-5","article-title":"Should cytoreductive surgery alone for peritoneal metastases of colorectal origin be centralized? A national study of 4159 procedures","volume":"31","author":"Noiret","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.111397_bib18","first-page":"1942","article-title":"The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the peritoneal surface oncology group international (PSOGI)","volume":"44","author":"Bushati","year":"2018","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2026.111397_bib19","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00330-019-06524-x","article-title":"Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis","volume":"30","author":"van \u2019t Sant","year":"2020","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111397_bib20","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/bjs.10527","article-title":"Evaluation of the peritoneal carcinomatosis index with CT and MRI","volume":"104","author":"Dohan","year":"2017","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2026.111397_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1245\/s10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111397_bib22","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1245\/s10434-024-16737-0","article-title":"Peritoneal cancer index correlates with radiographic assessment of colorectal carcinomatosis","volume":"32","author":"Fallon","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111397_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/bjs.10989","article-title":"Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery","volume":"106","author":"van \u2019t Sant","year":"2019","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.ejso.2026.111397_bib24","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1007\/s00330-024-11124-5","article-title":"Imaging of peritoneal metastases of ovarian and colorectal cancer: joint recommendations of ESGAR, ESUR, PSOGI, and EANM","volume":"35","author":"Vandecaveye","year":"2025","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111397_bib25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1245\/s10434-019-07219-9","article-title":"Correlation between intraoperative and pathological findings for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"26","author":"Berger","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2026.111397_bib26","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1245\/s10434-014-3647-0","article-title":"Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis","volume":"21","author":"Passot","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.111397_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.suronc.2020.02.014","article-title":"Impact of preoperative chemotherapy on the histological response of patients with peritoneal metastases from colorectal cancer according to peritoneal regression grading score (PRGS) and TRG","volume":"33","author":"Taibi","year":"2020","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2026.111397_bib28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1245\/s10434-015-4989-y","article-title":"Importance of absent neoplastic epithelium in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"23","author":"Enblad","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111397_bib29","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1245\/s10434-023-14608-8","article-title":"Actual 5-Year survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis of colorectal origin","volume":"31","author":"Sarfaty","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.111397_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3748\/wjg.v23.i3.377","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy for patients with colorectal cancer at high risk of peritoneal carcinomatosis: does it really save lives?","volume":"23","author":"Cortes-Guiral","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ejso.2026.111397_bib31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(20)30322-3","article-title":"Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study","volume":"21","author":"Go\u00e9r\u00e9","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2026.111397_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12885-018-4096-0","article-title":"HIPECT4: Multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma","volume":"18","author":"Arjona-S\u00e1nchez","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejso.2026.111397_bib33","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.3505","article-title":"Perioperative systemic therapy for resectable colorectal peritoneal metastases: a multicenter randomized phase 3 trial (CAIRO6)","volume":"43","author":"Rovers","year":"2025","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326000168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:51:56Z","timestamp":1775602316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326000168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0748798326000168"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111397","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgery for Colorectal Peritoneal Metastases in non-expert centers is strongly associated with tumor persistence or early recurrence: a bicentric study of 106 patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.111397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111397"}}